AZNCF - COVID-19 Vaccine Race Heats Up: Moderna Faces Off Against Pfizer And BioNTech
- PFE/BNTX have increased enrolment in their late-stage study of BNT162b2, leading many to speculate as to why.
- MRNA has not increased enrolment but slowed enrolment to focus on diversity.
- AZN has fallen behind a little in the US.
For further details see:
COVID-19 Vaccine Race Heats Up: Moderna Faces Off Against Pfizer And BioNTech